Page last updated: 2024-10-26

dipyridamole and Abdominal Pain

dipyridamole has been researched along with Abdominal Pain in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kocheril, SV1
Blaivas, M1
Appleton, BE1
McCune, WJ1
Ike, RW1
Oshima, T1

Other Studies

2 other studies available for dipyridamole and Abdominal Pain

ArticleYear
Degos' disease mimicking vasculitis.
    Arthritis and rheumatism, 2004, Jun-15, Volume: 51, Issue:3

    Topics: Abdominal Pain; Diagnosis, Differential; Dipyridamole; Drug Administration Schedule; Fatal Outcome;

2004
[Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:11

    Topics: Abdominal Pain; Adolescent; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroi

1997